FLT3-ITD microclones in AML and Results from the RESET-PV trial

In this week's episode, Blood editor Dr. Laura Michaelis interviews Drs. Pierre-Yves Dumas and Samik Basu on their latest articles published in Blood . Dr. Dumas talks about " Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy " where the team was able to identify that ultra-low-burden FLT3-ITD microclones are associated with…